(Q64149795)

English

A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution as Adjunctive Therapy With Vigabatrin as Initial Therapy in Patients With Infantile Spasms (English)

0 references

medical condition

spasm

0 references

country

United States of America

0 references

start time

5 September 2018

0 references

end time

December 2019